Man Ying Li

Miss Man Ying Li

Research Assistant

School of Medicine

College of Health

Date Type Title Institution Name Country Amount
2022 Award Basil Hetzel Institute Travel Grant Awards BHI, TQEH Australia -
2021 Award Best Oral Presentation Prize for Junior Laboratory Research TQEH Australia -
2020 Scholarship Faculty of Health and Medical Science Divisional Scholarships The Univeristy of Adelaide Australia -
2019 Achievement First Class Honours in Bachelor of Health and Medical Sciences The University of Adelaide Australia -
2019 Award THRF Honours Scholarships The Hospital Research Foundation Australia -
2019 Scholarship Summer Research Scholarships The University of Adelaide and SAHMRI Australia -

Date Institution name Country Title
2020 - 2024 University of Adelaide Australia PhD
2019 - 2019 University of Adelaide Australia Honours degree
2016 - 2018 University of Adelaide Australia Bachelor of Biomedical Science

Year Citation
2024 Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11.
DOI Scopus15 WoS12 Europe PMC10
2024 Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16.
DOI Scopus2 WoS1 Europe PMC2
2024 Li, C. M. Y., Briggs, M. T., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.. Clin Exp Med, 24(1), 53.
DOI Scopus9 WoS7 Europe PMC3
2024 Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), e7352-1-e7352-11.
DOI Europe PMC1
2023 Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages.
DOI Scopus3 WoS3 Europe PMC3
2023 Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17.
DOI Scopus20 WoS18 Europe PMC17
2022 Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages.
DOI Scopus14 WoS14 Europe PMC13

Connect With Me

External Profiles

Other Links